Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/337
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmaili, F.-
dc.contributor.authorBoudjella, A.-
dc.contributor.authorDib, A.-
dc.date.accessioned2023-03-20T14:28:00Z-
dc.date.available2023-03-20T14:28:00Z-
dc.date.issued2020-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/337-
dc.description.abstractBackground Breast cancer (BC) is a major health issue threatening women's life. No reliable epidemiological data on BC diagnosed by oncologists/senologists are available in Algeria. Methods The BreCaReAl study, a non-interventional prospective cohort study, included adult women with confirmed BC in Algeria. Disease incidence, patients and disease characteristics, treatment patterns, and mortality rate were recorded up to 12 months of follow-up. Results Overall, 1,437 patients were analysed: median age was 48 [41;57] years and 337 (23.5%) women had a family history of BC. BC incidence was 22.3 (95% CI: 21.5; 23.2) cases per 100,000 inhabitants over 8 months. Delayed diagnosis was reported in 400 (29.2%) patients. First line of treatments were mainly chemotherapy and surgery. Twenty-eight serious adverse events were reported including 10 (37.0%) events which led to death. Mortality rate reached 3.2% at 12 months Conclusion A delayed diagnosis highlights the importance of implementing more effective screening strategies.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesP20-05;-
dc.subjectBreast cancer ; Diagnosis ; Incidence ; Mortality ; Treatmenten_US
dc.titleEpidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeriaen_US
dc.typeArticleen_US
Appears in Collections:Publications électroniques

Files in This Item:
File Description SizeFormat 
P20-5.pdf562,35 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.